Argitalpenak (43) ELENA GOICOECHEA DE JORGE argitalpenak

2024

  1. Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis

    Kidney International, Vol. 105, Núm. 1, pp. 177-188

  2. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Kidney International

2023

  1. Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy

    Kidney360, Vol. 4, Núm. 5, pp. 659-672

  2. The Factor H protein family: The switchers of the complement alternative pathway

    Immunological Reviews, Vol. 313, Núm. 1, pp. 25-45

  3. Thrombotic microangiopathy in patients with malignant hypertension

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 5, pp. 1217-1226

2022

  1. C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies

    Nephrology Dialysis Transplantation, Vol. 37, Núm. 11, pp. 2128-2137

  2. Corrigendum: A Family Affair: Addressing the Challenges of Factor H and the Related Proteins (Front. Immunol., (2021), 12, (660194), 10.3389/fimmu.2021.660194)

    Frontiers in Immunology

  3. Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy

    Clinical Kidney Journal, Vol. 15, Núm. 9, pp. 1737-1746

  4. Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy

    Journal of the American Society of Nephrology : JASN, Vol. 33, Núm. 6, pp. 1137-1153

  5. Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 7, pp. 1270-1280

2021

  1. A Family Affair: Addressing the Challenges of Factor H and the Related Proteins

    Frontiers in Immunology, Vol. 12

  2. Molecular bases for the association of FHR-1 with atypical hemolytic uremic syndrome and other diseases

    Blood, Vol. 137, Núm. 25, pp. 3484-3494

  3. Validation of a Histologic Scoring Index for C3 Glomerulopathy

    American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1

2020

  1. Familial risk of developing atypical hemolytic-uremic syndrome

    Blood

2018

  1. Common and rare genetic variants of complement components in human disease

    Molecular Immunology, Vol. 102, pp. 42-57

2017

  1. Elevated factor H–related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy

    Kidney International, Vol. 92, Núm. 4, pp. 953-963

2015

  1. Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation

    Journal of Immunology, Vol. 194, Núm. 10, pp. 4963-4973

  2. Factor H-related proteins determine complement-activating surfaces

    Trends in Immunology, Vol. 36, Núm. 6, pp. 374-384

2014

  1. Competition between antagonistic complement factors for a single protein on N. meningitidis rules disease susceptibility

    eLife, Vol. 3

2013

  1. C3 glomerulopathy: Consensus report

    Kidney International